# Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders

> **NCT05638477** · NA · UNKNOWN · sponsor: **Conor Fearon** · enrollment: 122 (estimated)

## Conditions studied

- Parkinson's Disease and Parkinsonism
- Progressive Supranuclear Palsy
- Multiple System Atrophy
- Corticobasal Degeneration

## Interventions

- **BEHAVIORAL:** Free-viewing eye tracking

## Key facts

- **NCT ID:** NCT05638477
- **Lead sponsor:** Conor Fearon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2023-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05638477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05638477, "Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05638477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*